Share Samadhan Limited has announced the appointment of CS Pragya Bhansali as Company Secretary & Compliance Officer, effective January 19, 2026. The appointment was approved during the board meeting held on the same date and has been disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Appointment Details

The company has provided comprehensive details regarding the new appointment as required under regulatory guidelines:

Professional Background

Ms. Pragya Bhansali is a qualified Company Secretary (CS Professional) with significant experience in corporate governance, regulatory compliance, and capital market transactions. Her professional expertise encompasses several key areas that align with Share Samadhan's operational requirements.

She has been closely associated with Share Samadhan Limited's successful listing on the SME platform of BSE, where she contributed to various critical initiatives including pre-listing funding, corporate restructuring exercises, and coordination with merchant bankers, stock exchange officials, and other intermediaries.

Areas of Expertise

Ms. Bhansali possesses comprehensive knowledge and experience in multiple regulatory domains:

• Regulatory Compliance: Sound knowledge of compliances under the Companies Act, 2013
• SEBI Regulations: Expertise in SEBI (LODR) Regulations and SEBI (ICDR) Regulations
• Board Management: Experience in managing board and committee processes
• Documentation: Proficiency in drafting and reviewing offer documents
• Disclosure Compliance: Ensuring timely post-listing and continuous disclosure compliances

Corporate Governance Impact

The appointment strengthens Share Samadhan's corporate governance framework. Ms. Bhansali's structured approach and regulatory acumen are expected to support effective governance practices within the organization. Her experience with capital market transactions and regulatory compliance positions her well to handle the company's ongoing compliance requirements.

Regulatory Disclosure

The appointment has been formally communicated to BSE SME Exchange with scrip code 544251 and scrip ID SSL. The disclosure includes all required details pursuant to SEBI listing regulations, ensuring full transparency and regulatory compliance. The company has confirmed that there are no relationships between directors in connection with this appointment.

Share Samadhan Limited has officially confirmed the subscription of 1.5 million warrants by Choice International Limited, an NSE-listed company. The company disclosed this development through a regulatory filing, marking the completion of a significant milestone in its warrant allotment process and establishing a strategic partnership aimed at strengthening India's unclaimed investments recovery ecosystem.

Official Warrant Subscription Confirmation

The regulatory disclosure confirms the successful subscription by Choice International Limited:

Strategic Partnership Framework

According to Managing Director Abhay Kumar Chandalia, this strategic investment reflects Choice International's strong confidence in Share Samadhan's business model, growth trajectory, and long-term vision. The partnership creates powerful synergies across operations, technology, and market outreach, combining Share Samadhan's industry leadership with Choice International's diversified financial expertise.

Complete Warrant Distribution

The total warrant allotment of 3 million has been distributed among promoters and strategic investors:

Business Impact and Growth Prospects

The partnership is expected to accelerate Share Samadhan's expansion plans, enhance service capabilities, and deliver greater value to investors, partners, and stakeholders. This collaboration marks a significant milestone in the company's journey of scaling nationwide impact and pioneering transparency, trust, and efficiency in the investment retrieval domain.

Regulatory Compliance and Financial Framework

The preferential issue follows comprehensive regulatory compliance, including shareholder approval and BSE in-principle approval. The total potential capital infusion, if all warrants are converted, amounts to ₹234.00 crores, positioning the company for enhanced growth in the unclaimed investments recovery sector.